Close Menu
Beverly Hills Examiner

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Protons Lumo, a privacy-focused alternative to ChatGPT and Claude, arrives on desktop | TechCrunch

    November 17, 2026

    Man arrested after allegedly saying he had a bomb on a flight bound for New Orleans

    November 17, 2026

    Taylor Swifts Song of the Year Grammy Quip Was Likely No Accident

    November 17, 2026
    Facebook X (Twitter) Instagram
    Beverly Hills Examiner
    • Home
    • US News
    • Politics
    • Business
    • Science
    • Technology
    • Lifestyle
    • Music
    • Television
    • Film
    • Books
    • Contact
      • About
      • Amazon Disclaimer
      • DMCA / Copyrights Disclaimer
      • Terms and Conditions
      • Privacy Policy
    Beverly Hills Examiner
    Home»Business»FDA approves new shots from Pfizer, Moderna
    Business

    FDA approves new shots from Pfizer, Moderna

    By AdminSeptember 11, 2023
    Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    FDA approves new shots from Pfizer, Moderna

    [ad_1]

    A health-care worker prepares a dose of the Pfizer-BioNTech Covid-19 vaccine at a vaccination clinic in the Peabody Institute Library in Peabody, Massachusetts, Jan. 26, 2022.

    Vanessa Leroy | Bloomberg | Getty Images

    The Food and Drug Administration on Monday approved updated Covid vaccines from Pfizer and Moderna, putting the shots on track to reach Americans within days as U.S. hospitalizations from the virus rise.

    The agency has not made a decision on an updated Covid shot from Novavax.

    The new vaccines from Pfizer and Moderna are approved for people 12 and older and are authorized under emergency use for individuals 6 months through 11 years old, according to an FDA release. The agency noted that last year’s Covid boosters from the two companies are no longer authorized in the U.S.

    The Biden administration said last month that it expects the new single-strain vaccines targeting the omicron variant XBB.1.5 to be available to the public in mid-September. 

    The jabs still need a recommendation from the Centers for Disease Control and Prevention, which will determine who should get the shots. A CDC advisory panel is scheduled to meet Tuesday to vote on a recommendation for the vaccines. 

    The upcoming arrival of updated vaccines offers some reassurance to Americans as the nation sees an increase in Covid cases and hospitalizations. While the shots do not target the variants dominant now, the vaccine makers have said they will still offer protection against those strains as children return to school and the weather gets cooler.

    “We expect this season’s vaccine to be available in the coming days, pending recommendation from public health authorities,” Pfizer CEO Albert Bourla said in a release following the approval.

    He added that people can ask their doctors about receiving an updated Covid shot during the same appointment as their annual flu shot, “saving time now and helping to prevent severe disease later when respiratory viruses are at their peak.”

    Spokespeople for Moderna and Novavax did not immediately respond to a request for comment.

    Covid cases and hospitalizations still remain below the summer peak the nation saw last year. The uptick is fueled by newer – but closely related to XBB.1.5 – strains of the virus like EG.5, or Eris. That omicron strain accounted for 21.5% of all cases as of Sept. 2, according to the CDC. 

    Meanwhile, XBB.1.5 is declining in the U.S., the CDC said. 

    A resident receives a Covid-19 booster shots at a vaccine clinic inside Trinity Evangelic Lutheran Church in Lansdale, Pennsylvania, U.S, on Tuesday, Apr. 5, 2022.

    Hannah Beier | Bloomberg | Getty Images

    Pfizer, Moderna and Novavax have shared early trial data indicating their new shots still provide protection against Eris.

    Both Pfizer and Moderna have also said their updated shots produced a strong immune response against BA.2.86, a highly mutated omicron subvariant that health officials are watching closely.

    “The updated vaccines are expected to provide good protection against COVID-19 from the currently circulating variants,” the FDA said in the release on Monday.

    The upcoming vaccine rollout will be the first since the end of the U.S. Covid public health emergency, which expired in May. 

    The end of that declaration means the federal government will shift vaccine distribution to the private market, where manufacturers will sell their updated shots directly to health-care providers at higher prices. Previously, the government purchased vaccines directly from manufacturers at a discount to distribute to all Americans for free. 

    Private insurers and government payers like Medicare, which cover the vast majority of Americans, are expected to provide the vaccines to people for no fee. Federal efforts like the Biden administration’s Bridge Access Program are aiming to provide free Covid shots to uninsured people.

    The Biden administration will urge Americans to receive an updated Covid shot this fall, White House press secretary Karine Jean-Pierre said last week.

    “Vaccinations against Covid-19 remains the safest protection for avoiding hospitalization, long-term health outcomes, and death,” Jean-Pierre said during a briefing.

    But it’s unclear how many Americans will actually roll up their sleeves to get another shot in the coming months.

    Only around 17% of the U.S. population — around 56 million people — have received Pfizer and Moderna’s latest boosters since they were approved last September, according to the CDC. 

    [ad_2]

    Original Source Link

    Share. Facebook Twitter Pinterest LinkedIn WhatsApp Email Reddit Telegram
    Previous ArticleMan Who Killed Teenager He Allegedly Described As A ‘Republican Extremist’ Sentenced To Just 5 Years In Prison
    Next Article Venue Bans Puddle of Mudd After Cancellation, Blames Frontman

    RELATED POSTS

    The ultimate adulting task: signing up for health insurance | Fortune

    November 15, 2026

    Gen Z believes using AI is making their colleagues dumb and lazy, but may paradoxically see it as key to their own promotion, Wharton says | Fortune

    November 15, 2026

    Barack Obama says work-life balance isnt real for successful people | Fortune

    November 15, 2026

    Gen Zs job crisis has reached the ultrarich. Wealth advisors say billionaire parents are now planning for kids who may struggle to land and keep jobs | Fortune

    November 15, 2026

    Skims $148 advent calendar flop wasnt a stunt, marketers say—but store credit may not win back Kim Kardashians angry customers | Fortune

    November 15, 2026

    Lumen CFO expects up to $1.5 billion from legacy copper amid pivot to AI connectivity | Fortune

    November 12, 2026
    latest posts

    Protons Lumo, a privacy-focused alternative to ChatGPT and Claude, arrives on desktop | TechCrunch

    Proton, the privacy-focused tech company offering alternatives to Google and Microsoft’s tools for email, productivity…

    Man arrested after allegedly saying he had a bomb on a flight bound for New Orleans

    November 17, 2026

    Taylor Swifts Song of the Year Grammy Quip Was Likely No Accident

    November 17, 2026

    Everything to Know About the DWTS 2026 Finale

    November 17, 2026

    You Can See Everything Cinematographer on Billy Evans Nude Scene and Tension Between Him and the Team

    November 17, 2026

    Minivan crashes into people outside Los Angeles metro station, killing 3

    November 17, 2026

    Cybersecurity AI startup Corma reaches $1B valuation in about 3 months | TechCrunch

    November 17, 2026
    Categories
    • Books (1,613)
    • Business (6,518)
    • Cover Story (16)
    • Film (6,452)
    • Lifestyle (4,497)
    • Music (6,527)
    • Politics (6,502)
    • Science (5,858)
    • Technology (6,455)
    • Television (6,151)
    • Uncategorized (3)
    • US News (6,502)
    popular posts

    5 Myths and Misconceptions About Coffee (2022)

    [ad_1] Coffee is one of the most widely consumed psychoactive beverages on the planet. It’s…

    Book Riot’s Deals of the Day for July 27, 2025

    July 28, 2025

    The startup boom failed to build a creator utopia

    June 21, 2023

    Refilled wants to save 100 million plastic bottles from the landfill

    November 16, 2023
    Archives
    Browse By Category
    • Books (1,613)
    • Business (6,518)
    • Cover Story (16)
    • Film (6,452)
    • Lifestyle (4,497)
    • Music (6,527)
    • Politics (6,502)
    • Science (5,858)
    • Technology (6,455)
    • Television (6,151)
    • Uncategorized (3)
    • US News (6,502)
    About Us

    We are a creativity led international team with a digital soul. Our work is a custom built by the storytellers and strategists with a flair for exploiting the latest advancements in media and technology.

    Most of all, we stand behind our ideas and believe in creativity as the most powerful force in business.

    What makes us Different

    We care. We collaborate. We do great work. And we do it with a smile, because we’re pretty damn excited to do what we do. If you would like details on what else we can do visit out Contact page.

    Our Picks

    Minivan crashes into people outside Los Angeles metro station, killing 3

    November 17, 2026

    Cybersecurity AI startup Corma reaches $1B valuation in about 3 months | TechCrunch

    November 17, 2026

    Hayley Williams-Curated Outbreak Fest Features Dinosaur Jr., Blood Orange

    November 16, 2026
    © 2026 Beverly Hills Examiner. All rights reserved. All articles, images, product names, logos, and brands are property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Terms & Conditions and Privacy Policy.

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
    Cookie SettingsAccept All
    Manage consent

    Privacy Overview

    This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
    Necessary
    Always Enabled
    Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
    CookieDurationDescription
    cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
    cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
    cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
    cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
    cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
    viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
    Functional
    Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
    Performance
    Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
    Analytics
    Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
    Advertisement
    Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
    Others
    Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
    SAVE & ACCEPT